Group 1 - The resignation of Mr. Sun Bo from his positions as Chairman of the Supervisory Board, employee supervisor, and member of the Supervisory Board Nomination Committee will take effect on December 31, 2025, due to job relocation [1] - Mr. Sun Bo confirmed that there are no disagreements with the Supervisory Board and no matters related to his resignation that need to be disclosed to shareholders and creditors [1] - Mr. Sun Bo has completed the handover process in accordance with the company's regulations [1] Group 2 - During his tenure, Mr. Sun Bo emphasized the integration of party leadership and corporate governance, adhering to regulatory requirements and fulfilling his duties diligently [2] - He led the Supervisory Board in proactively assessing economic and financial conditions, focusing on strategic development and risk management, and enhancing the supervision mechanism [2] - The company and the Supervisory Board expressed their heartfelt gratitude for Mr. Sun Bo's hard work and significant contributions during his tenure [2]

薪酬与考核委员会：杨钧辉（主任委员、独立董事）、乔久华（独立董事）、蔡绍宽（独立董事）、崔 巍 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600487 证券简称：亨通光电 公告编号：2026-003号 江苏亨通光电股份有限公司 关于增补第九届董事会专门委员会委员的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 根据《江苏亨通光电股份有限公司（以下简称"公司"或"亨通光电"）章程》等法律法规及规范性文件的 规定，公司董事会各专门委员会均由5名董事组成。公司原董事鲍纪聪先生因工作调整，不再担任公司 第九届董事会董事、薪酬与考核委员会委员及环境、社会及治理（ESG）委员会委员职务；公司原董事 尹纪成先生因工作调整，不再担任公司第九届董事会董事、环境、社会及治理（ESG）委员会委员职 务。 为完善公司法人治理结构，公司于2025年12月30日召开第九届董事会第十三次会议，审议通过了《关于 增补第九届董事会专门委员会委员的议案》，同意选举董事钱建林先生为公司第九届董事会薪酬与考核 委员会委员；董事陆春良先生 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 二、董事会审议情况 1、审议通过《关于制定〈董事、高级管理人员薪酬管理制度〉的议案》 为进一步提升公司治理效能，提高公司规范运作水平，经董事会审议同意制定《董事、高级管理人员薪 酬管理制度》。 表决结果：同意 7 票，反对 0 票，弃权 0 票。 证券代码：301380 证券简称：挖金客 公告编号：2025-087 北京挖金客信息科技股份有限公司 第四届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 北京挖金客信息科技股份有限公司（以下简称"公司"）第四届董事会第三次会议于2025年12月30日以现 场结合通讯方式召开，会议通知于2025年12月19日以书面、电子邮件、电话等方式发出。本次会议由董 事长李征先生召集和主持，会议应参会董事7名，实际参会董事7名，其中以通讯方式出席会议的董事为 独立董事杨靖川先生、独立董事吴少华先生、独立董事汪浚先生。会议的召集、召开程序符合《公司 法》等相关法律法规及《公司章程》的规定。 该议案尚需提交公司股东会审议。 具体内容详 ...

Group 1 - The actual controller of Dongyun Co., Ltd., Yang Tao, was arrested for suspected illegal public deposit absorption, but the company's operations remain normal [1][3][5] - As of January 5, the stock price of Dongyun Co., Ltd. was 17.3 yuan per share, with a decline of 0.35% [2] - The company announced that Yang Tao does not hold any director or senior management positions, and the incident does not significantly impact corporate governance or daily operations [5] Group 2 - Dongyun Co., Ltd. disclosed that part of the shares held by its controlling shareholder, Beijing Yike Ruihai Mining Co., Ltd., have been judicially frozen due to litigation, totaling approximately 14.5 million shares [6][7] - If the frozen shares are executed and transferred, the controlling shareholder's holdings would decrease from approximately 31.8 million shares (23.04% of total shares) to about 17.3 million shares (12.53% of total shares), potentially affecting the stability of control [7] - For the first three quarters of 2025, Dongyun Co., Ltd. reported revenue of approximately 406 million yuan, a year-on-year increase of 7.94%, but a net loss of approximately 2.68 million yuan compared to a profit of 11.25 million yuan in the same period of 2024 [7]

Core Viewpoint - YZi Labs accuses CEA Industries' board of implementing a poison pill strategy and amending bylaws to entrench board power and weaken shareholder rights, while demanding fair nomination and election processes for the 2025 shareholder meeting [1] Group 1 - YZi Labs claims that CEA Industries' defensive measures are aimed at solidifying board control and diminishing shareholder influence [1] - YZi denies the assertion that the company "never considered alternative tokens," stating that management had evaluated other assets [1] - CEA Industries responds by asserting that its board governance is compliant and welcomes shareholder communication, emphasizing its commitment to a BNB-centric DAT strategy [1] Group 2 - CEA Industries currently holds approximately 516,000 BNB [1]

金鸿顺的董事会正在动荡之中。2025年12月22日，金鸿顺（股票代码：603922）第二大股东高德投资有限公司（以下简称高德投资）以金鸿顺董事长刘栩 缺席两次董事会会议，且自2025年9月底起已不到公司现场履职为由，提议免去刘栩非独立董事职位，同时一并免去提名委员会委员等一系列职务。 这场罢免被部分员工视为保护公司正常运转的必要手段。在此之前，与刘栩关系密切的王海宝已在12月10日被免去副董事长一职。但据金鸿顺2026年1月4 日晚间披露的最新公告，罢免刘栩的议案未能通过。超5400万股投出反对票，与刘栩名下海南众德科技有限公司（以下简称海南众德）的持股量大致相 当。 最新公告显示，海南众德还曾利用金鸿顺全资子公司北京金鸿顺科技有限公司（以下简称北京金鸿顺）的公章对外借贷1.25亿元，如今剩余7500万元待 还。 针对借款及履职等问题，1月4日晚间，《每日经济新闻》记者尝试拨打刘栩电话，但未能接通。 1月4日，上交所向金鸿顺下发监管工作函，事关公司股东会及子公司涉诉有关事项，涉及对象为上市公司，控股股东及实际控制人，中介机构及其相关人 员。 官网截图 缺席的上市公司实控人 大概是在2025年9月底，金鸿顺的员 ...

Macro and Strategy Research - The manufacturing PMI for December 2025 is reported at 50.1%, indicating a return to the expansion zone after 8 months, with improvements in both production and demand [2][3] - The production index increased by 1.7 percentage points to 51.7%, attributed to reduced uncertainties from the external trade environment [3] - The new orders index rose by 1.6 percentage points to 50.8%, marking the first return to expansion in the second half of the year [3] - New export orders increased by 1.4 percentage points to 49.0%, showing a significant slowdown in contraction, while the import index continued to contract [3] - The December non-manufacturing business activity index rose by 0.7 percentage points to 50.2%, returning to the expansion zone, driven significantly by the construction sector [4] - The comprehensive PMI output index increased by 1.0 percentage point to 50.7%, reflecting a rebound in both manufacturing and non-manufacturing sectors [4] - The outlook for January 2026 suggests continued expansion in manufacturing due to a stable external trade environment and the gradual implementation of incremental policies [4] U.S. Monetary Series - The Federal Reserve's balance sheet is crucial for understanding changes in dollar liquidity, primarily through "bilateral accounting" methods [6][7] - The Fed's balance sheet has been in an expansion trend since its inception, influenced by economic development and institutional changes [7] - The historical changes in the Fed's balance sheet can be divided into four phases, with the most recent phase (2020-present) seeing accelerated expansion due to the pandemic [7] Financial Engineering Research - Company governance is identified as a critical component of corporate competitiveness, directly affecting resource allocation efficiency, profitability sustainability, and risk management [9] - A well-governed company enhances operational quality and market profitability expectations, leading to a steady increase in stock prices [9][10] - The report outlines six dimensions of corporate governance that impact stock pricing, including shareholder behavior, debt management, and ESG scores [10][11] - Future research will focus on the interaction effects of governance indicators, heterogeneity across different scenarios, and the development of a multidimensional governance evaluation system [11]

西安曲江文化旅游股份有限公司 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600706证券简称：曲江文旅（维权） 编号：临2026-007 一、已在2025年半年度报告披露的诉讼（仲裁）进展 单位：万元 ■ 二、半年度报告披露后的其他重大诉讼（仲裁） 单位：万元 ■ 截至本公告披露日，公司及控股子公司不存在尚未披露的重大诉讼（仲裁）事项。 特此公告。 关于重大诉讼（仲裁）事项的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 西安曲江文化旅游股份有限公司（以下简称"公司"）根据《上海证券交易所股票上市规则》有关规定， 对公司及控股子公司重大诉讼（仲裁）事项公告如下： 西安曲江文化旅游股份有限公司董事会 2026年1月1日 证券代码：600706证券简称：曲江文旅 编号：临2026-006 西安曲江文化旅游股份有限公司 关于以实物资产抵债 暨关联交易进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、基本概况 西安 ...

Core Viewpoint - Shandong Zhanggu's financial information disclosure violations have led to an investigation by the China Securities Regulatory Commission (CSRC), indicating a significant escalation in regulatory scrutiny [1][2][3] Regulatory Actions - The CSRC's investigation follows a previous administrative corrective action by the Shandong Securities Regulatory Bureau, which identified three major issues: violations in related party transactions, improper use of raised funds, and non-compliance in corporate governance [2][3] - The shift from "administrative correction" to "suspected illegal violations" reflects a more serious regulatory stance [3] Internal Control and Governance Issues - The identified violations reveal deep-seated problems in Shandong Zhanggu's internal controls and governance structure, including ineffective management of related party transactions and weak financial control systems [4] - The company's governance has been criticized for a lack of compliance culture and insufficient independence of internal audits, leading to ineffective oversight by independent directors and supervisory boards [4] Changes in Governance Structure - Following the investigation, the state-owned shareholder, Jinan Zhangqiu District Public Asset Management Company, has increased its involvement in the company's governance by adding more non-independent directors to key committees [4][5] - This shift aims to enhance the protection of state assets, but it also faces challenges such as role conflicts and the need for rapid operational turnaround [5] Business Performance and Challenges - Shandong Zhanggu's core business, which includes the production and sale of fans and industrial pumps, has shown weak growth and declining profit margins [5] - The company has attempted to diversify through investments in various sectors, totaling approximately 300 million yuan, but these efforts have not yielded significant results [5] - The company's net profit attributable to shareholders fell by 39.12% year-on-year in the first three quarters of 2025, highlighting the pressure on its financial performance [5]

Core Insights - In 2025, Guangdong Tianenkang Pharmaceutical Co., Ltd. (referred to as "Tianenkang") is committed to the core philosophy of "putting investors first," focusing on information disclosure, corporate governance, market value management, and social responsibility to enhance compliance and steadily increase corporate value [1][2] Group 1: Corporate Achievements - Tianenkang has received multiple authoritative awards for its outstanding performance in innovation research and development, market value management, corporate governance, and ESG practices, reflecting broad market recognition of its high-quality development [1] - On December 15, 2025, Tianenkang was included in the sample range of the CSI 1000 Index, indicating robust fundamental operations and good market liquidity, which marks its investment value recognized by index compilers [1] - The company launched an employee stock ownership plan on August 5, 2025, to stimulate internal motivation and inject strong momentum for long-term development [1] Group 2: Investor Relations Management - Tianenkang has established multiple communication channels for investor relations, holding two performance briefings and receiving over 200 institutional visits throughout the year, including six research meetings with various institutions [2] - The company responded to 51 investor inquiries on the interactive platform, focusing on key investor concerns such as CKBA clinical progress and product development pipeline [2] - In 2025, Tianenkang laid a solid foundation for high-quality development through precise information disclosure, an efficient governance system, innovative market value management, and solid ESG practices, with plans to deepen investor communication and optimize capital operation strategies [2]